Home/ Supplements/ Niacin/ Oxydrene NAD+ Enhancer

Oxydrene NAD+ Enhancer

product on market Capsule Novex Biotech Safety: 92/100
92/100

This product looks safe

  • Niacin: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)
  • 80% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula combines Niacin and Coenzyme Q10 to support cellular energy and NAD+ levels, while Rhodiola rosea and L-Tryptophan are used for cognitive and mood support. Research evidence for these individual components is generally moderate to strong, though specific evidence for this exact blend is limited. The profile maintains a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Oxydrene NAD+ Enhancer
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Vegetable Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
80%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

500 mg (3125% DV)
Exceeds UL by 14.3× (UL: 35 mg) 196 studies (A:5, B:63)
0.5 mg (56% DV)
Within RDA (0.6× RDA) 37 studies (A:0, B:11)
220 mg
Market median: 500.0mg (70 products)
Market median: 300.0mg (122 products) 22 studies (A:0, B:7)
30 mg
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)

Other Ingredients

Rice Flour Hypromellose Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, take 2 capsules one hour before physical activity or as recommended by your health-care professional. Individual results may vary.

Warnings & Precautions

Note: If you are an athlete competing under International Olympic Committee (IOC) or World Anti-Doping Agency (WADA) rules, it should be noted that the IOC and WADA have banned any substance that artificially enhances the uptake, transport, or delivery of oxygen. Because this ban might include Oxydrene NAD+ Enhancer (due to its ability to increase oxygen uptake at peak exercise levels), competitive athletes should check with their trainers and governing bodies before using Oxydrene NAD+ Enhancer in organized athletic competition.

Warning: Do not exceed suggested daily serving. Not for use by individuals under the age of 18 years.

Do not use if pregnant or nursing. Consult your physician before use if you are taking medication or have a medical condition.

Do not use if inner safety seal under cap is broken or missing. Use only as directed.

Keep out of reach of children.

Formulation Notes

Clinically validated to increase VO2 max!!!

Increases NAD+ levels Increases VO2 max Optimizes systemic oxygen utilization Increases energy Increases endurance Supports cardiovascular health

Additional Information

Product resale allowed only through authorized representatives. International distribution is not authorized without prior written approval.

Store at controlled room temperature: 15 degrees to 30 degrees C / 50 degrees to 86 degrees F

If you or your health-care provider have any questions, or for more information regarding our money-back guarantee, please call our customer service team: 1-800-898-5153.

Metadata

Product Details

UPC / SKU8 56528 00169 8
DSLD Entry Date2020-06-24
Product TypeOther Combinations
FormCapsule
DSLD ID228783
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.